Physician profile
Ryan K Hand
NPI 1497864623
$871.00
in general payments reported to CMS, 2019-2025
11 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $253 · 2022: $127 · 2023: $151 · 2024: $239 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $491.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $267.94 | 2021-2024 | Signia |
| Biotissue Holdings INC. | $123.05 | 2021 | |
| Smith+Nephew, INC. | $96.11 | 2021-2025 | Allevyn Heel 10.5cm X 13.5cm Ctn 5, Pico |
| Baxter Healthcare | $93.64 | 2022-2024 | Tisseel |
| Becton, Dickinson and Company | $81.92 | 2023 | Phasix Mesh |
| Solventum Corporation | $58.64 | 2024-2025 | V.A.C. Veraflo, Prevena |
| Kci USA, INC. | $56.79 | 2022 | |
| Abbvie INC. | $39.82 | 2022 | |
| Ethicon US, LLC | $21.64 | 2024 | Vistaseal |
| Astellas Pharma US INC | $17.00 | 2025 | Padcev |
| Aroa Biosurgery Incorporated | $14.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Hand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.